Development of Antisense Drugs for Dyslipidemia
Abnormal elevation of low-density lipoprotein (LDL) and triglyceride-rich lipoproteins in plasma as well as dysfunction of anti-atherogenic high-density lipoprotein (HDL) have both been recognized as essential components of the pathogenesis of atherosclerosis and are classified as dyslipidemia. This...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Japan Atherosclerosis Society
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090806/ |